IPAMORELIN (5mg)

What is Dragon Pharma Ipamorelin?
Dragon Pharma Ipamorelin is a laboratory-formulated growth hormone secretagogue (GHS) supplied in a sterile lyophilized peptide vial for research applications. Ipamorelin is a selective ghrelin receptor (GHS-R1a) agonist, designed to stimulate the body's natural release of growth hormone (GH) without significantly affecting cortisol or prolactin levels. Unlike earlier GHRP compounds, ipamorelin is known for its receptor specificity and comparatively mild side-effect profile in experimental models. It is widely investigated in studies involving muscle recovery, fat metabolism, anti-aging pathways, and sleep regulation. Because it promotes endogenous GH secretion rather than supplying synthetic hormone directly, ipamorelin is categorized as a regulatory peptide rather than an anabolic steroid or exogenous hormone replacement agent.

Mechanism of Action:
Ipamorelin works by binding selectively to the growth hormone secretagogue receptor (GHS-R1a) in the pituitary and hypothalamus. Activation of this receptor stimulates pulsatile release of growth hormone, mimicking the body's natural secretion pattern. Increased GH subsequently elevates IGF-1 production in the liver and peripheral tissues, enhancing processes such as protein synthesis, tissue repair, lipolysis, and cellular regeneration. Importantly, ipamorelin demonstrates high selectivity, meaning it has minimal impact on other endocrine pathways, including cortisol and prolactin secretion. This targeted mechanism makes it particularly attractive in research focused on lean mass preservation, metabolic optimization, and recovery physiology, while reducing the risk of broad hormonal disruption.

Benefits:

• Stimulates natural growth hormone release
• Supports muscle recovery and lean tissue maintenance
• Enhances fat metabolism and body composition research
• May improve sleep quality and recovery cycles

Research Applications:

• Study of GH pulsatility and endocrine regulation
• Investigation of muscle regeneration and protein synthesis pathways
• Research on fat metabolism and metabolic efficiency
• Exploration of age-related decline in growth hormone production

Dosing Instructions:

• Dosing: Typically 100–200 mcg per administration in research studies
• Daily Dose: Administered 1–3 times per day based on experimental protocols
• Route: Subcutaneous (SC) or intramuscular (IM) injection
• Duration: Usually 4–8 weeks per research cycle
• Frequency: Once to three times daily depending on study design
• Recommended Cycles: Determined by research objectives, often 4–8 weeks
• PCT: Not applicable; strictly for laboratory and research use

Stacking With Other Products:

• Combined with CJC-1295 DAC to enhance sustained GH signaling
• Studied alongside BPC 157 for tissue repair research
• Paired with GHK-Cu in regenerative and anti-aging protocols
• Integrated with AOD 9604 in body composition studies

Side Effects:

• Mild injection-site irritation
• Temporary water retention in some research subjects
• Increased hunger due to ghrelin receptor activity
• Occasional headache or fatigue during initial use

Contraindications:

• Active malignancy due to GH stimulation considerations
• Pregnancy or breastfeeding
• Known hypersensitivity to peptide components
• Severe uncontrolled endocrine disorders

Conclusion
Dragon Pharma Ipamorelin is a selective growth hormone secretagogue valued in research for its ability to promote natural GH and IGF-1 elevation without broad endocrine disruption. By targeting the ghrelin receptor with high specificity, it supports investigations into muscle regeneration, fat metabolism, sleep quality, and age-related hormonal decline. Its pulsatile stimulation pattern aligns closely with physiological hormone release, making it distinct from exogenous GH administration. While preclinical and clinical research demonstrates promising applications, long-term safety data remain under continued evaluation. As with all investigational peptides, proper sterile handling, accurate measurement, and structured research design are essential to ensure safe and reliable outcomes.

References:

• Raun K, et al. "Ipamorelin: A Selective Growth Hormone Secretagogue." European Journal of Endocrinology.
• Smith RG, et al. "Ghrelin Receptor Agonists and GH Secretion." Endocrine Reviews.
• Svensson J, et al. "Effects of Growth Hormone Secretagogues on IGF-1 Levels." Clinical Endocrinology.
• ClinicalTrials.gov – Studies Evaluating Ipamorelin in Hormonal Regulation Research.

Ipamorelin FAQ

✔️ What is Ipamorelin used for?
Ipamorelin is commonly used to support natural growth hormone release, which may help with muscle recovery, fat metabolism, and overall performance support.

✔️ How does Ipamorelin work in the body?
Ipamorelin stimulates the pituitary gland to release growth hormone by activating ghrelin receptors, helping the body produce its own GH naturally.

✔️ What benefits are associated with Ipamorelin?
Many people use Ipamorelin to support lean muscle development, improved recovery, better sleep quality, and enhanced fat metabolism.

✔️ How is Ipamorelin typically administered?
Ipamorelin is usually administered through a subcutaneous injection after the peptide is properly reconstituted with bacteriostatic water.

✔️ How long does Ipamorelin take to show results?
Some users report improvements in sleep and recovery within a few weeks, while body composition changes may appear after several weeks of consistent use.

✔️ Can Ipamorelin be stacked with other peptides?
Yes, Ipamorelin is often combined with peptides such as CJC‑1295 to enhance growth hormone release and overall peptide synergy.

✔️ Are there any possible side effects?
Ipamorelin is generally well tolerated, but some users may experience mild headaches, increased appetite, or temporary injection site irritation.

✔️ How should Ipamorelin be stored after reconstitution?
After mixing with bacteriostatic water, Ipamorelin should be stored in a refrigerator (2–8°C) to maintain stability and peptide potency.

Storage and Safety – Dragon Pharma Ipamorelin

Proper storage and strict safety measures are essential to maintain the potency, purity, and effectiveness of Dragon Pharma Ipamorelin. Each vial should be stored in a refrigerated environment at 2–8°C (36–46°F) and protected from direct sunlight, heat, and moisture, all of which can negatively impact the peptide’s stability and biological activity.

Storage Guidelines

• Keep the vial sealed when not in use to maintain integrity.

• After reconstitution with sterile water, store the solution in the refrigerator and avoid freezing, as extreme temperatures can damage the peptide structure.

• Protect from light and humidity, which can reduce shelf life and effectiveness.

Handling Safety

• Handle with sterile gloves or clean hands to prevent contamination.

• Use disposable syringes for single-use administration to ensure safe and hygienic usage.

• Keep out of reach of children, pets, and unauthorized personnel.

• Adhere to recommended dosage guidelines and only use under approved research or medical protocols.

Important Notes

• Improper storage or handling may reduce biological activity, potency, and therapeutic results.

• Following proper safety practices ensures Dragon Pharma Ipamorelin remains stable, reliable, and fully effective for intended growth hormone stimulation and anti-aging benefits.

• Always inspect the vial integrity before use to confirm the peptide has been stored under optimal conditions.